SGCB and atherosclerosis: In this study, we sought to specifically investigate the role of platelet sGC in atherosclerosis because we found that carriers of the common, noncoding risk variant rs7692387 identified by GWAS4 displayed reduced expression of sGC in platelets and, as a consequence, reduced inhibition of platelet aggregation on NO stimulation7.